VCs upbeat about European life sciences market, despite uncertainty

VCs upbeat about European life sciences market, despite uncertainty

Life sciences companies that can demonstrate unique value propositions, or show promising early signs of success, can earn investor confidence. Investors are willing to commit larger sums than ever before to companies they believe in.

CBRE Report for West Yorkshire Combined Authority highlights need for life sciences grow-on space in region

A new report by CBRE, commissioned by West Yorkshire Combined Authority (WYCA), has highlighted the acute need for more grow-on space for life sciences, and in particular digital health companies if the region is going to fulfill its potential and retain its home-grown talent.CBRE’s research found that with over 600 health and life sciences companies, including 250 MedTech firms and over 90 digital health enterprises, West Yorkshire is emerging …